arginin esteras cystic fibrosi pancrea arginin esteras activ chloroformellag acidtr plasma 11 patient cystic fibrosiscf 12 agematch control subject resolv compon fraction ion exchang chromatographi deaesephadex electrofocus polyacrylamid gel activ resolv two fraction chromatographi one inhibit soybean trypsin inhibitor sti inhibit sti plasma cf patient fraction activ inhibit sti reduc approxim 30 correspond fraction control plasma contrast fraction activ resist inhibit sti show signific quantit differ control cf plasma sampl analysi plasma sampl electrofocus 5 polyacrylamid gel rang ph 5080 subsequ stain arginin esteras activ show qualit differ control cf plasma sampl six activ band could detect control sampl wherea five band detect cf sampl eight sampl one type band miss two anoth type band miss one yet anoth type band miss band restrict narrow ph zone center gel data consist extend earlier report differ arginin esteras activ plasma sampl cf patient control subject demonstr absenc singl band arginin esteras activ consist absenc specif arginin esteras isoenzym patient cf defici arginin esteras patient cystic fibrosi may account presenc factor saliva plasma fibroblast patient consequ clinic manifest diseas